These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9390770)

  • 1. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease.
    Lovell MA; Ehmann WD; Mattson MP; Markesbery WR
    Neurobiol Aging; 1997; 18(5):457-61. PubMed ID: 9390770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease.
    Markesbery WR; Lovell MA
    Neurobiol Aging; 1998; 19(1):33-6. PubMed ID: 9562500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease.
    Calingasan NY; Uchida K; Gibson GE
    J Neurochem; 1999 Feb; 72(2):751-6. PubMed ID: 9930749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype.
    Montine KS; Reich E; Neely MD; Sidell KR; Olson SJ; Markesbery WR; Montine TJ
    J Neuropathol Exp Neurol; 1998 May; 57(5):415-25. PubMed ID: 9596412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders.
    Di Domenico F; Tramutola A; Butterfield DA
    Free Radic Biol Med; 2017 Oct; 111():253-261. PubMed ID: 27789292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.
    Reed TT; Pierce WM; Markesbery WR; Butterfield DA
    Brain Res; 2009 Jun; 1274():66-76. PubMed ID: 19374891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of 4-hydroxynonenal-histidine Michael adduct in the hippocampi of patients with Alzheimer's disease.
    Fukuda M; Kanou F; Shimada N; Sawabe M; Saito Y; Murayama S; Hashimoto M; Maruyama N; Ishigami A
    Biomed Res; 2009 Aug; 30(4):227-33. PubMed ID: 19729853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease.
    Williams TI; Lynn BC; Markesbery WR; Lovell MA
    Neurobiol Aging; 2006 Aug; 27(8):1094-9. PubMed ID: 15993986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Hydroxynonenal oxidatively modifies histones: implications for Alzheimer's disease.
    Drake J; Petroze R; Castegna A; Ding Q; Keller JN; Markesbery WR; Lovell MA; Butterfield DA
    Neurosci Lett; 2004 Feb; 356(3):155-8. PubMed ID: 15036618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products.
    Sultana R; Butterfield DA
    Neurochem Res; 2004 Dec; 29(12):2215-20. PubMed ID: 15672542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics identification of carbonylated and HNE-bound brain proteins in Alzheimer's disease.
    Sultana R; Butterfield DA
    Methods Mol Biol; 2009; 566():123-35. PubMed ID: 20058169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanism for the neuroprotective effect of apolipoprotein E: isoform-specific modification by the lipid peroxidation product 4-hydroxynonenal.
    Pedersen WA; Chan SL; Mattson MP
    J Neurochem; 2000 Apr; 74(4):1426-33. PubMed ID: 10737598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease.
    Lovell MA; Xie C; Markesbery WR
    Neurology; 1998 Dec; 51(6):1562-6. PubMed ID: 9855502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment.
    Butterfield DA; Reed T; Perluigi M; De Marco C; Coccia R; Cini C; Sultana R
    Neurosci Lett; 2006 Apr; 397(3):170-3. PubMed ID: 16413966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau.
    Mattson MP; Fu W; Waeg G; Uchida K
    Neuroreport; 1997 Jul; 8(9-10):2275-81. PubMed ID: 9243625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease.
    Cenini G; Sultana R; Memo M; Butterfield DA
    J Cell Mol Med; 2008 Jun; 12(3):987-94. PubMed ID: 18494939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-hydroxynonenal and neurodegenerative diseases.
    Zarkovic K
    Mol Aspects Med; 2003; 24(4-5):293-303. PubMed ID: 12893007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification.
    Takeda A; Smith MA; Avilá J; Nunomura A; Siedlak SL; Zhu X; Perry G; Sayre LM
    J Neurochem; 2000 Sep; 75(3):1234-41. PubMed ID: 10936206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of 4-hydroxynonenal, a cytotoxic product of lipid peroxidation, in rat precision-cut liver slices.
    Laurent A; Perdu-Durand E; Alary J; Debrauwer L; Cravedi JP
    Toxicol Lett; 2000 Apr; 114(1-3):203-14. PubMed ID: 10713486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures.
    Lovell MA; Xie C; Markesbery WR
    Neurobiol Aging; 2001; 22(2):187-94. PubMed ID: 11182468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.